- Report
- October 2025
- 86 Pages
Middle East
From €4295EUR$4,850USD£3,711GBP
- Report
- February 2026
- 240 Pages
United States
From €4295EUR$4,850USD£3,711GBP
- Report
- August 2025
- 146 Pages
Asia Pacific
From €3187EUR$3,599USD£2,754GBP
- Report
- August 2025
- 121 Pages
Latin America
From €3187EUR$3,599USD£2,754GBP
- Report
- August 2025
- 102 Pages
Africa, Europe, Middle East Africa, Europe, Middle East
From €3187EUR$3,599USD£2,754GBP
- Report
- August 2025
- 113 Pages
North America
From €3187EUR$3,599USD£2,754GBP
- Report
- May 2026
Middle East
From €3533EUR$3,990USD£3,053GBP
- Report
- May 2026
Asia Pacific
From €3533EUR$3,990USD£3,053GBP
- Report
- May 2026
United States
From €3533EUR$3,990USD£3,053GBP
- Report
- May 2026
- 67 Pages
United States
From €1196EUR$1,350USD£1,033GBP
- Report
- May 2026
- 150 Pages
Europe
From €1683EUR$1,900USD£1,454GBP
- Report
- April 2024
- 318 Pages
Global
From €5210EUR$6,089USD£4,350GBP
- Newsletter
- May 2026
- 8 Pages
China
From €2789EUR$3,149USD£2,410GBP
- Report
- August 2025
- 115 Pages
India
From €3099EUR$3,499USD£2,678GBP
- Report
- December 2025
- 153 Pages
Japan
From €4915EUR$5,550USD£4,247GBP
- Report
- March 2024
- 132 Pages
Global
From €4118EUR$4,650USD£3,558GBP
- Report
- October 2024
- 100 Pages
Global
From €5269EUR$5,950USD£4,553GBP
- Report
- July 2024
- 120 Pages
Global
From €5269EUR$5,950USD£4,553GBP
- Report
- September 2023
- 90 Pages
Global
From €5269EUR$5,950USD£4,553GBP
- Report
- September 2023
- 175 Pages
Global
From €5269EUR$5,950USD£4,553GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more